GALK1 Gene Galactokinase Deficiency Genetic Test
At DNA Labs UAE, we offer the GALK1 Gene Galactokinase deficiency genetic test. This test is used to diagnose and assess the severity of Galactokinase deficiency, a rare genetic disorder.
Test Components and Price
The GALK1 Gene Galactokinase deficiency genetic test is priced at 3200.0 AED. The test can be performed using blood samples, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
The test results are typically delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes.
Test Type and Doctor
The GALK1 Gene Galactokinase deficiency genetic test falls under the category of metabolic disorders. It is recommended to consult with a general physician for this test.
Test Department and Pre Test Information
The GALK1 Gene Galactokinase deficiency genetic test is conducted by our Genetics department. Prior to the test, a genetic counseling session is recommended to gather clinical history and draw a pedigree chart of family members affected by Galactokinase deficiency.
Test Details
The GALK1 gene encodes the galactokinase enzyme, which is involved in the metabolism of galactose, a sugar found in lactose. Galactokinase deficiency is a rare genetic disorder characterized by the body’s inability to properly break down galactose, resulting in an accumulation of galactose-1-phosphate.
NGS genetic testing, used in the context of Galactokinase deficiency, analyzes the entire coding region of the GALK1 gene to identify any mutations or variations that may be causing the disorder. This comprehensive assessment can aid in diagnosis, determining disease severity, predicting clinical outcomes, and informing treatment options.
NGS genetic testing has revolutionized the field of genetic medicine by enabling faster and more accurate diagnoses. It allows for the simultaneous analysis of multiple genes, providing a more comprehensive understanding of the genetic basis of various disorders. This facilitates personalized treatment approaches and improves patient outcomes.
| Test Name | GALK1 Gene Galactokinase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 3200.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GALK1 Gene Galactokinase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Galactokinase deficiency |
| Test Details |
The GALK1 gene is responsible for encoding the enzyme galactokinase, which plays a crucial role in the metabolism of galactose, a sugar found in lactose (milk sugar). Galactokinase deficiency is a rare genetic disorder characterized by the inability to properly break down galactose, leading to an accumulation of galactose-1-phosphate in the body. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of galactokinase deficiency, NGS genetic testing can be used to identify any mutations or variations in the GALK1 gene that may be causing the disorder. By analyzing the entire coding region of the GALK1 gene, NGS genetic testing can provide a comprehensive assessment of genetic variations that may be associated with galactokinase deficiency. This information can be valuable for diagnosis, determining disease severity, predicting clinical outcomes, and informing treatment options. NGS genetic testing is a powerful tool in the field of genetic medicine, as it allows for the simultaneous analysis of multiple genes, providing a more comprehensive understanding of the genetic basis of various disorders. It has revolutionized the field of genetic testing, enabling faster and more accurate diagnoses, and facilitating personalized treatment approaches. |
